ArticleBlood cancer journal2019

Mass cytometry dissects T cell heterogeneity in the immune tumor microenvironment of common dysproteinemias at diagnosis and after first line therapies.

Taxiarchis V Kourelis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.